This metabolic mechanism is tightly regulated by a cholesterol homeostatic network that includes the LXR, low-density lipoprotein particle receptor (LDLR) and sterol response element binding protein (SREBP),[6] the mechanism of LXR in cancer cell cholesterol metabolism is expected to be a new target for many types of cancer. The gene discussed is LDLR; the disease is cancer.